Citizens & Northern Corp Has $1.86 Million Stock Position in CVS Health Corporation (NYSE:CVS)

Citizens & Northern Corp raised its position in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 65.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,520 shares of the pharmacy operator's stock after purchasing an additional 10,887 shares during the period. Citizens & Northern Corp's holdings in CVS Health were worth $1,864,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Hopwood Financial Services Inc. acquired a new position in CVS Health during the fourth quarter valued at approximately $29,000. McIlrath & Eck LLC grew its stake in shares of CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after buying an additional 174 shares during the last quarter. MV Capital Management Inc. grew its stake in shares of CVS Health by 63.9% during the first quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator's stock worth $50,000 after buying an additional 289 shares during the last quarter. Dunhill Financial LLC grew its stake in shares of CVS Health by 147.2% during the first quarter. Dunhill Financial LLC now owns 749 shares of the pharmacy operator's stock worth $51,000 after buying an additional 446 shares during the last quarter. Finally, Financial Perspectives Inc grew its stake in shares of CVS Health by 137.5% during the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after buying an additional 466 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at CVS Health

In related news, Director Guy P. Sansone acquired 1,570 shares of the company's stock in a transaction dated Thursday, June 5th. The shares were purchased at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the acquisition, the director now owns 12,007 shares of the company's stock, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 1.22% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have weighed in on CVS shares. Barclays set a $79.00 target price on shares of CVS Health and gave the stock an "overweight" rating in a research note on Monday, June 2nd. Royal Bank Of Canada boosted their target price on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research note on Monday, May 5th. Robert W. Baird boosted their target price on shares of CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Wells Fargo & Company reaffirmed an "overweight" rating and set a $84.00 target price (up previously from $76.00) on shares of CVS Health in a research note on Tuesday, May 6th. Finally, Cowen reissued a "buy" rating on shares of CVS Health in a research note on Monday, May 5th. Two research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $74.75.

CVS Health Trading Up 0.5%

CVS traded up $0.36 during trading on Monday, reaching $66.93. 6,845,085 shares of the stock traded hands, compared to its average volume of 10,907,184. The company has a quick ratio of 0.63, a current ratio of 0.82 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $84.67 billion, a PE ratio of 15.97, a P/E/G ratio of 0.95 and a beta of 0.56. The stock's 50-day moving average is $64.88 and its 200 day moving average is $60.53. CVS Health Corporation has a 12 month low of $43.56 and a 12 month high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. The business had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business's quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.31 earnings per share. Equities analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.